Evidence-Based Medicine Guidelines
Metformin vs. combined oral contraceptive pills for symptoms and risks associated with polycystic ovary syndrome
Metformin vs. combined oral contraceptive pills for symptoms and risks associated with polycystic ovary syndrome is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Metformin Vs. Combined Oral Contraceptive Pills for Symptoms and Risks Associated With Polycystic Ovary Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452829/all/Metformin_vs__combined_oral_contraceptive_pills_for_symptoms_and_risks_associated_with_polycystic_ovary_syndrome.
Metformin vs. combined oral contraceptive pills for symptoms and risks associated with polycystic ovary syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452829/all/Metformin_vs__combined_oral_contraceptive_pills_for_symptoms_and_risks_associated_with_polycystic_ovary_syndrome. Accessed March 25, 2023.
Metformin vs. combined oral contraceptive pills for symptoms and risks associated with polycystic ovary syndrome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452829/all/Metformin_vs__combined_oral_contraceptive_pills_for_symptoms_and_risks_associated_with_polycystic_ovary_syndrome
Metformin Vs. Combined Oral Contraceptive Pills for Symptoms and Risks Associated With Polycystic Ovary Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452829/all/Metformin_vs__combined_oral_contraceptive_pills_for_symptoms_and_risks_associated_with_polycystic_ovary_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Metformin vs. combined oral contraceptive pills for symptoms and risks associated with polycystic ovary syndrome
ID - 452829
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452829/all/Metformin_vs__combined_oral_contraceptive_pills_for_symptoms_and_risks_associated_with_polycystic_ovary_syndrome
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
